Nymox Pharmaceutical
NYMX
#9963
Rank
S$24.33 M
Marketcap
Country
$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.71 Million, an increase over its 2021 earnings that were of -S$16.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-65.17%
2022 -S$8.71 Million-47.71%
2021 -S$16.65 Million6.61%
2020 -S$15.62 Million-10.91%
2019 -S$17.53 Million24.24%
2018 -S$14.11 Million-20.03%
2017 -S$17.64 Million2.71%
2016 -S$17.17 Million-63.86%
2015 -S$47.52 Million674.44%
2014 -S$6.14 Million-6.11%
2013 -S$6.54 Million-35.66%
2012 -S$10.16 Million-20.76%
2011 -S$12.82 Million38.33%
2010 -S$9.27 Million35.59%
2009 -S$6.84 Million11.8%
2008 -S$6.12 Million-12.94%
2007 -S$7.03 Million8.85%
2006 -S$6.46 Million36.5%
2005 -S$4.73 Million-4.4%
2004 -S$4.95 Million-14.58%
2003 -S$5.79 Million
2001 -S$4.25 Million-20.54%
2000 -S$5.35 Million21.72%
1999 -S$4.39 Million-25.56%
1998 -S$5.9 Million101.3%
1997 -S$2.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.03 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.25 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.56 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.90 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.25 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA